Your shopping cart is currently empty

Synonyms: d-(RYTVELA) acetate(868844-53-5 Free base)
d-
(RYTVELA) acetate

| Description | d-(RYTVELA) acetate is a specific inhibitor of human thymocyte proliferation with an IC50 value of 1 nM. d-(RYTVELA) inhibits IL-1-induced signaling pathways. d-(RYTVELA) is therefore valuable for investigations involving cytokine-mediated immune regulation, thymocyte biology, inflammatory signaling cascades, and IL-1-associated cellular responses. |
| In vivo | d-(RYTVELA) acetate (1mg/kg; i.p.; twice-daily) diminishes the number of TUNEL-positive apoptotic cells in rats[1]. d-(RYTVELA) acetate (1mg/kg; i.p.; twice-daily) selectively reduced OIR-generated (augmented) SAPK/JNK pathway while preserving intact the important immuno-vigilant related NF-κB axis as measured directly in retinal tissue[1]. |
| Synonyms | d-(RYTVELA) acetate(868844-53-5 Free base) |
| Sequence | {D-(Arg-Tyr-Thr-Val-Glu-Leu-Ala)} |
| Sequence Short | RYTVELA |
| Storage | Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.